TP53 and neoplasm: As a positive control for enhanced tumorigenesis, the p53−/− strain (76) had significantly higher tumor incidence (average 27.58% per clutch, p=0.0117) as well as more tumors per animal (average 2.79 tumors per animal, p<0.0001, Supplemental Figure 9), confirming the system’s sensitivity.